13F Holdings
中文EN

MCTA Charming Medical Ltd Annual reports only

Services-Misc Health & Allied Services, NEC · SEC CIK 2035992

Financial factors as of 2026-03-31 (FY2026), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-22.7%
TTM net income YoY-101.9%
TTM EPS YoY-100.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin99.3%
Operating margin-0.6%
Net margin-0.5%
FCF margin-32.4%
EBITDA margin3.9%

Returns

ROE-0.9%
ROA-0.3%
ROIC (approx.)-34.1%
Asset turnover0.63x

Leverage & solvency

Liabilities / assets47.5%
Debt / equity0.07x
Current ratio1.89x
Interest coverage-1.85x

Cash quality & payout

Operating cash flow / net income53.69x
Accruals ratio15.7%
Payout ratio—
Capex / revenue7.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20262026-03-31FY20252025-03-31FY20242024-03-31
Income statement
Revenue$4.81M$6.22M$6.02M
Cost of revenue$35,221$15,514$11,294
Gross profit$4.77M$6.21M$6.00M
Operating income-$29,237$1.39M$1.01M
Interest expense$15,799$20,874$26,051
Pretax income$133,466$1.44M$1.00M
Income tax$156,114$236,082$181,751
Net income-$22,648$1.20M$777,811
EBITDA$186,837$1.65M$1.40M
EPS (basic)0.000.080.05
EPS (diluted)0.000.080.05
Weighted avg. shares (diluted)16.15M15.34M15.34M
Balance sheet
Cash & equivalents$4.70M$816,771$2.10M
Receivables$201,477$395,901—
Inventory$25,623$26,797—
Current assets$8.17M$3.37M—
PP&E, net$606,901$500,053—
Total assets$9.87M$5.36M—
Current liabilities$4.33M$4.95M—
Short-term debt$185,799$314,226—
Long-term debt$185,799——
Total debt$371,598——
Total liabilities$4.69M$5.31M—
Shareholders' equity$5.18M$49,243-$1.15M
Net debt-$4.33M——
Cash flow statement
Operating cash flow-$1.22M$425,888$295,429
Capital expenditure$339,560$287,527$210,598
Free cash flow-$1.56M$138,361$84,831
Investing cash flow-$179,015-$2.23M-$210,598
Financing cash flow$5.29M$521,303$100,145
Depreciation & amortization$216,074$263,454$391,704

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.